{'text': 'Phase 3 Head-to-Head ENDEAVOR Study Demonstrates Superiority Of Kyprolis速 (carfilzomib) Over Velcade速 (bortezomib) In Patients With Relapsed Multiple Myeloma', 'publisher': {'href': 'https://www.prnewswire.com', 'title': 'PR Newswire'}, 'created_at': 'Sun, 01 Mar 2015 08:00:00 GMT', 'description': 'Phase 3 Head-to-Head ENDEAVOR Study Demonstrates Superiority Of Kyprolis速 (carfilzomib) Over Velcade速 (bortezomib) In Patients With Relapsed Multiple Myeloma  PR Newswire', 'url': 'https://news.google.com/rss/articles/CBMisAJBVV95cUxPQ0t2Uk5OUV9LaE5CLTg1UEU2VGRCSG5Ia1ZlLTlQbDdpem1ZRDNvZVU3MjFXSlM1YXFvSFdFS0xBNjFMSnFoVWZERzBZdExqSER6UTE5WjVMMXB3Qkp0SEtNblBOQmd1SGhxbC13QldXYjJzQi1TOHhBTGRkaHdVSm84V0JxS1VOaGFidEs1S3E0Y1VrWmZUSHlfNy1sWW55dDdiZ19oYXJjYmV0OVhuZG82dkU2cTBaOWtRVXVTV0U4MlZ5SlBOM0pKc2R6RnAwUEEwWVg3eW9FaFkteDVzcHNkLVEtb0RmZE81LTRFTUtwOG9fTVQtdU5DSDVIVUNvWjZnV2wzemVpOUd3VDN1UnN0UnBUdV94am1sU2Z1YXlSTjUybDBScVhBRDU5alhv?oc=5&hl=en-US&gl=US&ceid=US:en'}
